These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16527822)

  • 1. Novel peptide inhibitors of human kallikrein 2.
    Hekim C; Leinonen J; Närvänen A; Koistinen H; Zhu L; Koivunen E; Väisänen V; Stenman UH
    J Biol Chem; 2006 May; 281(18):12555-60. PubMed ID: 16527822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.
    Janssen S; Jakobsen CM; Rosen DM; Ricklis RM; Reineke U; Christensen SB; Lilja H; Denmeade SR
    Mol Cancer Ther; 2004 Nov; 3(11):1439-50. PubMed ID: 15542783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.
    Saedi MS; Zhu Z; Marker K; Liu RS; Carpenter PM; Rittenhouse H; Mikolajczyk SD
    Int J Cancer; 2001 Nov; 94(4):558-63. PubMed ID: 11745444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.
    Lövgren J; Airas K; Lilja H
    Eur J Biochem; 1999 Jun; 262(3):781-9. PubMed ID: 10411640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
    Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
    Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors.
    Pakkala M; Hekim C; Soininen P; Leinonen J; Koistinen H; Weisell J; Stenman UH; Vepsäläinen J; Närvänen A
    J Pept Sci; 2007 May; 13(5):348-53. PubMed ID: 17436344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.
    Réhault S; Monget P; Mazerbourg S; Tremblay R; Gutman N; Gauthier F; Moreau T
    Eur J Biochem; 2001 May; 268(10):2960-8. PubMed ID: 11358513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
    Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW
    Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology.
    Cloutier SM; Chagas JR; Mach JP; Gygi CM; Leisinger HJ; Deperthes D
    Eur J Biochem; 2002 Jun; 269(11):2747-54. PubMed ID: 12047384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.
    Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H
    Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.
    Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS
    Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of peptides specifically modulating the activity of KLK2 and KLK3.
    Koistinen H; Närvänen A; Pakkala M; Hekim C; Mattsson JM; Zhu L; Laakkonen P; Stenman UH
    Biol Chem; 2008 Jun; 389(6):633-42. PubMed ID: 18627344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
    Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
    Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.
    Mikolajczyk SD; Millar LS; Marker KM; Grauer LS; Goel A; Cass MM; Kumar A; Saedi MS
    Eur J Biochem; 1997 Jun; 246(2):440-6. PubMed ID: 9208936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
    Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
    Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human glandular kallikrein, hK2, in mammalian cells.
    Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
    Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.
    Bourgeois L; Brillard-Bourdet M; Deperthes D; Juliano MA; Juliano L; Tremblay RR; Dubé JY; Gauthier F
    J Biol Chem; 1997 Nov; 272(47):29590-5. PubMed ID: 9368023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.